AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes
Nicolas Basty(University of Westminster), Christina Messiou(Institute of Cancer Research), Kevin Boyd(Royal Marsden Hospital), Katy Smith(Memorial Sloan Kettering Cancer Center), Karen Thomas(Royal Glamorgan Hospital), Simon Doran(Institute of Cancer Research), Alina Dragan(Royal Marsden NHS Foundation Trust), Charlotte Pawlyn(Royal Marsden NHS Foundation Trust), Martin Kaiser(Royal Marsden NHS Foundation Trust), Núria Porta, Robby Emsley(Royal Marsden NHS Foundation Trust), Davide Meo(Royal Marsden NHS Foundation Trust), Jessica Winfield(University Hospitals Birmingham NHS Foundation Trust), Dow-Mu Koh(Royal Marsden NHS Foundation Trust), Brandon Whitcher(Royal Marsden NHS Foundation Trust)
Cited by 0
Related Papers
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
|Journal of Clinical Oncology|2015|564